Sage Therapeutics, Inc. Restructuring Costs
Sage Therapeutics, Inc. reported Restructuring Costs of $300.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2025-07-30
- Sage Therapeutics, Inc. restructuring costs for the quarter ending 2025-06-30 was -$200.00K.
- Sage Therapeutics, Inc. restructuring costs for the quarter ending 2025-03-31 was $500.00K.
- Sage Therapeutics, Inc. restructuring costs for the quarter ending 2023-09-30 was $33.60M.
- Sage Therapeutics, Inc. restructuring costs for fiscal 2024 was $22.30M, a 33.23% decline from fiscal 2023.
- Sage Therapeutics, Inc. restructuring costs for fiscal 2023 was $33.40M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 12 month |
|---|---|---|---|
| 2025-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $300.00K 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $500.00K 10-Q · filed 2025-04-29 | ||
| 2024-12-31 | $22.30M 10-K · filed 2025-02-11 | ||
| 2023-12-31 | $33.40M 10-K · filed 2025-02-11 | ||
| 2023-09-30 | $33.60M 10-Q · filed 2023-11-07 |